-
Analyst Opinions
NewFlavors and Fragrances – Consumer Survey Insights
Flavors and Fragrances - Consumer Survey Overview Flavors and fragrances play a crucial role in product positioning as they enhance the sensorial side of consumption. When reaching for a new flavor, almost 70% of global consumers claim that their main motivation is curiosity. The importance of flavors and fragrances is evident across all market sectors, as many categories utilize these product features as unique selling points. The consumer interest in new flavors and fragrances can also be largely attributed to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tolvaptan in Polycystic Kidney Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tolvaptan in Polycystic Kidney Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tolvaptan in Polycystic Kidney Disease Drug Details: Tolvaptan (Samsca, Samtasu)...
-
Thematic Analysis
NewState of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update) – Thematic Intelligence
Reasons to buy the ‘State of the Biopharmaceutical Industry 2024’ thematic intelligence report: Highlight the business environment and the industry, regulatory, and macroeconomic trends that are going to shape the biopharmaceutical industry in the next 12 months. Benchmark the impact of major themes on the biopharmaceutical industry in the next 12 months, Identify themes that will have the greatest positive or negative impact in the coming months. Comprehend the opinions of industry respondents on these themes. Predict the industry’s growth prospects...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Castration-Resistant Prostate Cancer (CRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab in Castration-Resistant Prostate Cancer (CRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golimumab in Castration-Resistant Prostate Cancer (CRPC) Drug Details: Golimumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golimumab in Type 1 Diabetes (Juvenile Diabetes) Drug...
-
Product Insights
NewMedRhythms Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MedRhythms Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MedRhythms Inc (MedRhythms) is a digital therapeutics company that uses sensors, music, and software to build neurologic interventions, evidence-based, to measure and improve walking. MedRhythms is headquartered in Boston, Massachusetts, the US. GlobalData's Medical Devices company profile report, “MedRhythms Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company...
-
Product Insights
NewBlue Note Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Blue Note Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Blue Note Therapeutics Inc (Blue Note Therapeutics) is a healthcare technology company that offers a digital therapeutics platform to deliver evidence-based therapeutic interventions to patients that are driven by software programs to prevent, manage and treat a medical disorder. Blue Note Therapeutics is headquartered in San Francisco, California, the US. GlobalData's Medical Devices company profile report, “Blue Note...
-
Product Insights
NewCureApp Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our CureApp Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. CureApp Inc (CureApp) is a developer of digital therapeutics prescription application with medical equipment and software based on medical evidence. The company offers portable instrument for measuring CO levels in breath integrated treatment; CureApp NASH for liver treatment; and ascure mental health & smoking cessation programs. CureApp is headquartered in Tokyo, Japan. GlobalData's Medical Devices company profile report, “CureApp Inc...
-
Product Insights
NewAlgoDx AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our AlgoDx AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. AlgoDx AB (AlgoDx) improves patient outcomes using machine learning technology. The company develops precision medicine using evidence-based algorithm diagnostics and artificial intelligence solutions. AlgoDx is headquartered in Stockholm, Sweden. GlobalData's Medical Devices company profile report, “AlgoDx AB Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides...
-
Product Insights
NewImmunovia AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Immunovia AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Immunovia AB (Immunovia) is a molecular diagnostics company. It offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease progression, and monitoring the therapeutic responsiveness of cancers. Immunovia’s IMMray can also be used for biomarker discovery through...